Some antiepileptic medicines may affect fetal growth and development, though risks vary by drug and dose. Managing epilepsy during pregnancy means weighing medication concerns against seizure risks, with careful clinical monitoring for the health of both parent and baby.

Multiple Choice

What is a common side effect associated with the use of antiepileptic medications in pregnant women?

Antiepileptic medications are commonly associated with a range of side effects, particularly when used during pregnancy. One of the notable concerns is their potential impact on fetal development. Research has shown that certain antiepileptic drugs can interfere with normal fetal growth, leading to an increased risk of developmental delays and other congenital issues. This is particularly important for healthcare providers to monitor in pregnant women who are taking these medications. While drowsiness is a general side effect of many antiepileptic drugs, it is not specific to pregnancy. Weight loss and increased appetite are less commonly associated with antiepileptic medications, as many tend to lead to weight gain rather than loss. The potential for delay in fetal development due to exposure to these medications is a significant consideration, emphasizing the need for careful management of epilepsy in pregnant women to mitigate risks to both the mother and fetus.

Antiepileptic Medication During Pregnancy: Protecting Two Lives at Once

For someone living with epilepsy, pregnancy brings an important balancing act. Seizures can pose serious risks to both the pregnant person and the fetus, yet some antiepileptic medications can affect fetal growth or development. The goal is not simply to avoid medication. It’s to find the safest effective treatment and manage it carefully throughout pregnancy.

These medicines are also called antiseizure medications or anticonvulsants. They help control seizures by changing electrical activity in the brain. Many people rely on them every day, and stopping suddenly can trigger seizures—even after a long period without one. That’s why decisions about treatment need to be made with a healthcare professional, not by changing a dose on one’s own.

What fetal development concerns mean

Some antiepileptic medications are linked with a higher chance of birth defects or other effects on fetal development. The level of risk varies by drug, dose, timing, and whether more than one medication is used. It isn’t accurate to treat all medicines in this group as having the same effects.

Possible concerns include structural differences that form early in pregnancy, changes in fetal growth, and, for some drugs, later effects on learning or development. These outcomes aren’t certain. Many pregnancies involving antiepileptic medication result in healthy babies. Still, the known risks matter because a clinician may be able to reduce them while keeping seizures controlled.

Valproate is a key example. Exposure during pregnancy is associated with a greater risk of certain birth defects and developmental problems than exposure to several other antiseizure medicines. For this reason, clinicians often consider whether another effective medication could be used before pregnancy. But changing treatment is a personal medical decision: a drug that carries lower fetal risk may not control a particular person’s seizures as well.

Other medicines, including lamotrigine and levetiracetam, are often considered when selecting treatment for someone who may become pregnant. They are not risk-free, and the right choice depends on seizure type, medical history, past response, and other factors. The medication that works best for one person may not be suitable for another.

Maternal side effects still matter

Fetal development gets much of the attention, but the pregnant person’s health matters just as much. Drowsiness, dizziness, nausea, and coordination problems can occur with some antiseizure medications. These effects vary across drugs and individuals; they aren’t unique to pregnancy. A dose that causes fatigue before pregnancy may feel different as the body changes, so new or worsening symptoms deserve a conversation with a clinician.

Weight changes can occur too, but they depend on the medication. Some drugs are linked with weight gain, while others may affect appetite or weight in different ways. A single side effect shouldn’t be assumed to apply to the entire medication group.

There’s another complication: pregnancy can change how the body processes medicine. Blood levels of some drugs may fall as pregnancy progresses, even when the dose stays the same. For certain medications, that drop can make seizures more likely. Clinicians may check drug levels and symptoms over time, then adjust the dose when needed. After delivery, medication levels can shift again, so follow-up remains important.

Why seizure control is part of fetal safety

It can feel as though medication is the only risk in the picture. It isn’t. Uncontrolled seizures can cause falls, injuries, reduced oxygen, and other complications. A severe seizure may be dangerous for the pregnant person and fetus. So the safest plan must weigh both medication exposure and the harm that seizures could cause.

That’s why abruptly stopping an antiseizure medication can be dangerous. Even a well-intentioned change made without medical advice may lead to breakthrough seizures. If pregnancy is planned, a clinician can review the treatment in advance, when there may be more time to consider a gradual change and assess whether it works. If pregnancy has already begun, prompt medical guidance is still useful—there’s no need to make changes alone.

Care may involve a neurologist and an obstetric clinician, sometimes with a maternal-fetal medicine specialist. This team can look at the full picture: the person’s seizure history, the medicine and dose, other health conditions, and the stage of pregnancy. Clear communication matters, especially when care comes from more than one clinic.

Before and during pregnancy

For someone who could become pregnant, a conversation about medication can be helpful even before pregnancy is on the horizon. Clinicians may review whether the current drug remains suitable, whether one medication can control seizures instead of several, and whether the dose is as low as it can be while still working. “As low as possible” does not mean too low to prevent seizures; control remains central.

Folic acid is another part of the discussion. It supports early fetal development, and a clinician may recommend supplementation for people taking antiseizure medication. The suggested amount can vary based on the medication and individual health needs, so it’s best to ask for specific guidance rather than assume one dose fits everyone.

Once pregnancy begins, regular follow-up helps track both seizure control and medication effects. Depending on the drug, care may include blood tests, dose reviews, and routine checks of fetal growth. After birth, the plan may need another review because the body’s handling of medication can return toward its pre-pregnancy pattern. Breastfeeding can also be discussed; many people taking antiseizure medication can breastfeed, though advice depends on the specific drug and the baby’s health.

A careful plan, not a simple yes or no

Antiepileptic medication in pregnancy calls for thoughtful planning, not fear. Certain drugs can affect fetal development, and the size and type of risk differ from one medication to another. At the same time, seizure control protects the pregnant person and the fetus.

The most useful next step is an individual plan made with qualified clinicians—ideally before pregnancy, but also if pregnancy is unexpected. With the right medication review and follow-up, many people with epilepsy have healthy pregnancies while continuing the care they need.